• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOSENSE WEBSTER INC THERMOCOOL SMARTTOUCH SF; CARDIAC ABLATION PERCUTANEOUS CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOSENSE WEBSTER INC THERMOCOOL SMARTTOUCH SF; CARDIAC ABLATION PERCUTANEOUS CATHETER Back to Search Results
Catalog Number D134701
Medical Device Problem Code Patient Device Interaction Problem (4001)
Health Effect - Clinical Code Cardiac Tamponade (2226)
Date of Event 10/15/2025
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster inc., or its employees that the report constitutes an admission that the product, biosense webster inc., or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Manufacturer's ref.# (b)(4).
 
Event or Problem Description
After and atrial fibrillation (afib) ablation procedure with a thermocool smarttouch sf catheter and the patient experienced pericardial effusion (pe) with a drop blood pressure.Patient was treated with pericardiocentesis.After the case, a pericardial effusion was noticed during a standard post procedure check.No issues were reported during the procedure but after the pericardial effusion was observed, the patient had a drop in blood pressure.Pe was confirmed by intracardiac echocardiography (ice).Medical intervention provided was pericardiocentesis.The patient was reported to be in stable condition.The physician believes the pericardial effusion was related to the transseptal puncture.It was a difficult transseptal puncture and they had to do it twice during the procedure.They also had high force in one area, but the physician believes it was due to the transseptal puncture.Additional information was later received indicating the patient¿s outcome from the adverse event was improved.The patient required extended hospitalization.Relevant tests/laboratory data was act<350.
 
Additional Manufacturer Narrative
On 24-nov-2025, the bwi product analysis lab received the complaint device for evaluation.The product analysis has begun but is not completed at this time.When the investigational analysis has been completed, a supplemental 3500a report will be submitted.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's ref.# (b)(4).
 
Additional Manufacturer Narrative
After and atrial fibrillation (afib) ablation procedure with a thermocool smarttouch sf catheter and the patient experienced pericardial effusion (pe) with a drop blood pressure.Patient was treated with pericardiocentesis.Device evaluation details: the product was returned to johnson & johnson medtech (j&j medtech) for evaluation.A visual inspection and revision of all features were performed following j&j medtech procedures.Visual analysis revealed no damage or anomalies on the device.The device features were reviewed, and no issues were observed during the product investigation.A manufacturing record evaluation was performed for the finished device batch number, and no internal actions were identified.No malfunction was observed during the product analysis.The root cause of the adverse event remains unknown.In addition, no device malfunction was reported, there may have been other circumstances or issues that occurred during the use of the device that could not be replicated during the analysis.The instruction for use (ifu) states that careful catheter manipulation must be performed to avoid cardiac damage, perforation, or tamponade.As part of johnson & johnson medtech¿s quality process, all devices are manufactured, inspected, and released to approved specifications.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's ref.# (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
THERMOCOOL SMARTTOUCH SF
Common Device Name
CARDIAC ABLATION PERCUTANEOUS CATHETER
Manufacturer (Section D)
BIOSENSE WEBSTER INC
31 technology drive, suite 200
irvine CA 92618
Manufacturer (Section G)
BIOSENSE WEBSTER INC (JUAREZ)
circuito interior norte
1820parque industrial salvacar
juarez 32599
MX   32599
Manufacturer Contact
henry boden
31 technology dr
irvine, CA 92618
9497882078
MDR Report Key23522129
Report Number2029046-2025-03763
Device Sequence Number13230932
Product Code LPB
UDI-Device Identifier10846835009774
UDI-Public(01)10846835009774(17)280725(10)31704904L
Combination Product (Y/N)N
Initial Reporter CountryUS
PMA/510(K) Number
P030031
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Other
Type of Report Initial,Followup,Followup
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Catalogue NumberD134701
Device Lot Number31704904L
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 10/15/2025
Supplement Date Received by Manufacturer11/24/2025
12/10/2025
Initial Report FDA Received Date11/11/2025
Supplement Report FDA Received Date11/25/2025
12/19/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured07/26/2025
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
CARTO 3 SYSTEM.; SMARTABLATE GENERATOR KIT-US.; SMARTABLATE PUMP SPARE-US.
Outcome Attributed to Adverse Event Hospitalization; Required Intervention;
Patient Age78 YR
Patient SexFemale
Patient Weight60 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-